Gene Query: GPC3

Dataset Description Geneva Score
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 192.43
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 158.68
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 119.05
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 106.81
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 104.54
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 101.54
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 87.14
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 74.48
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 72.85
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 72.85
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 65.66
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 65.3
Single-nucleotide-resolution mapping of HBV promoters using CAGE 64.02
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 61.95
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 61.67
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 60.35
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 58.37
Global analyses of the effect of different cellular contexts on microRNA targeting 58.37
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 58.34
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 58.34
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 54.98
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 54.24
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 53.03
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 52.89
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 52.14
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 50.93
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 50.84
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 49.93
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 49.67
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 48.28
Evolution of a transcriptional regulator from a transmembrane nucleoporin 47.8
RNA-seq in HepG2 and IMR90 cells 47.8
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 47.45
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 46.41
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 45.97
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 45.91
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 45.27
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 44.58
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 44.58
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 44.55
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 44.36
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 43.81
RNA-Seq from early time points in the kidney differentiation protocol 43.71
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 41.85
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 41.85
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 41.61
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 41.31
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 40.69
Gene expression changes associated with resistance to tagraxofusp (SL-401) 37.3
CHCHD10 gene KO effect in iPSC drived motor neurons 36.71
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 36.52
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 34.74
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 34.68
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 34.3
DIGIT regulates endoderm differentiation of human embryonic stem cells 33.94
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 32.3
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 31.24
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 31.24
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 31.03
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 30.81
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 30.76
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 30.28
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 29.86
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 29.63
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 29.63
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 29.44
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 28.51
Epigenomic landscape during organ formation in human early embryos 28.44
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 27.85
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 27.75
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 27.73
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 27.7
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 27.59
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 27.59
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 27.38
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 27.29
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 27.24
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 26.94
Lineage specific differentiation is influenced by state of human pluripotency 26.94
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 26.89
Morphological and molecular characterization of human dermal lymphatic collectors 26.63
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 26.45
Triple vectors expand AAV transfer capacity in the retina 25.64
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 25.43
Overexpression and knockdown experiment for circCSNK1G3 25.3
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 25.13
Subtle asymmetry of gene expression in embryonic and foetal human brains 25.12
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 25.02
MARS Seq data from human cortical organoids 24.83
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 24.79
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 24.79
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 24.56
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 24.05
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 23.55
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 23.26
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 23.1
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 23.1
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 22.93
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 22.87
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 22.75
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 22.74
Global expression profiles in cardiac progenitor cells generated by ISX-9 22.69
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 22.69
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 22.69
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 22.42
Disruption of GRIN2B impairs differentiation in human neurons 22.41
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 21.56
Transcriptomic profile of human embryonic renal corpuscles 21.51
Transcriptional landscape changes during human embryonic stem cell derivation 21.45
In vitro modeling of human germ cell development using pluripotent stem cells 21.43
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 21.32
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 21.29
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 21.07
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 21.07
Primary human trophoblast from term placenta 20.73
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 20.65
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 20.63
Total RNA sequencing of WT intestinal orgaonids. 20.56
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 20.28
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 20.19
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 20.18
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 20.11
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 20.0
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 19.66
Epigenome regulation during epidermal lineage commitment 19.06
AMPK signaling for naïve pluripotency 18.95
AMPK signaling for naïve pluripotency [Hs] 18.95
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 18.9
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 18.81
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 18.79
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 18.76
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 18.74
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 18.7
High level DNA repair gene expression in human ES cells 18.65
High-efficiency RNA-based reprogramming of human primary fibroblasts 18.59
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 18.46
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 18.45
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 18.3
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 18.27
Regionally specified human pluripotent stem cell-derived astrocytes 18.08
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 18.04
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 17.99
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 17.92
RNA sequencing analysis of human embryonic stem cells and axial progenitors 17.76
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 17.75
O-glcnAc reprograms cellular energetics 17.57
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 17.55
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 17.48
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 17.38
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 17.28
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 17.26
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 17.02
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 16.94
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 16.92
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 16.92
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 16.84
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 16.82
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 16.77
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 16.77
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 16.68
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 16.52
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 16.51
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 16.24
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 16.19
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 16.13
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 16.12
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 15.99
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 15.77
Differences in miRNA Detection Levels are Technology and Sequence Dependent 15.77
iPSC-Derived Cholangiocytes 15.43
Human embryonic stem cells in E8 and AKIT culture medium 15.42
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 15.42
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 15.38
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 15.1
Epigenome regulation during epidermal lineage commitment [RNA-seq] 15.1
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 15.08
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 15.05
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 14.96
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 14.89
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 14.75
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 14.74
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 14.73
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 14.72
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 14.44
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 14.44
Examining serotonergic neuron differentiation from human iPSCs 14.3
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 14.27
Gene expression patterns define the hepatocyte-like cells derived by different strategies 14.27
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 14.18
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 14.18
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 14.18
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 14.18
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 14.13
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 14.12
Cerebellar differentiation in Ataxia-Telangiectasia 14.12
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 14.12
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 13.89
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 13.86
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 13.86
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 13.77
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 13.72
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 13.64
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 13.61
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 13.52
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 13.47
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 13.47
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 13.45
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 13.29
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 13.24
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 13.24
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 13.11
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 13.09
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 13.06
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 13.05
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 13.02
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 12.99
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 12.92
Gene profiling of human adult and pediatric liver cancer cells 12.9
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 12.82
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 12.82
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 12.8
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 12.76
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 12.7
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 12.7
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 12.61
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 12.52
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 12.49
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 12.47
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 12.22
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 12.05
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 12.03
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 11.79
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 11.74
Expression profiles of the four human major ectodermal lineages 11.57
A practical evaluation of alignment algorithms for RNA variant calling analysis 11.35
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 11.31
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 11.29
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 11.23
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 11.2
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 11.15
FGF2 regulation of gene expression in stable inducible Neurons 11.14
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 11.11
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 11.09
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 11.09
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 11.07
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 11.05
Tracking of dCas9-methyltransferase footprints 10.96
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 10.87
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.86
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 10.82
MYCL and EP400 are required for Max and MCPyV mediated gene activation 10.77
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 10.69
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 10.57
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 10.57
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 10.57
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.54
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 10.52
Dynamic reorganization of nuclear architecture during human cardiogenesis 10.52
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 10.51
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.46
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 10.42
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 10.4
An acquired vulnerability of drug resistant melanoma with therapeutic potential 10.31
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 10.31
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 10.14
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 10.1
Global transcriptome analysis of WT versus HEB-/- hESCs 10.09
Gene expression analysis of human hepatocellular cancers 10.0
RNA-seq analysis of RALD iPSCs after in vitro differentiation 10.0
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.85
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.81
RNA-seq in endometrial stromal tumors 9.75
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.59
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 9.55
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 9.55
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 9.48
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 9.48
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 9.38
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.34
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 9.31
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 9.3
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.27
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 9.25
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 9.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.2
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.2
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 9.13
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 9.13
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.12
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 9.08
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 8.99
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 8.99
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.94
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 8.94
Transcriptome analysis of virus infected tissues 8.92
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 8.92
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 8.84
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 8.8
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 8.8
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 8.75
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 8.73
Gene expression and genome-wide location analysis of breast cancer cell-lines 8.68
Gene expression analysis of breast cancer cell-lines 8.68
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 8.41
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 8.41
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 8.35
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 8.35
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 8.29
iPSC derived motor neuron cultures from C9ORF72 carriers 8.24
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 8.18
Tumor exosome integrins determine organotropic metastasis 8.15
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 8.14
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 8.07
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 8.06
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 8.0
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 7.74
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.74
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 7.71
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 7.7
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 7.67
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 7.65
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 7.57
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.53
hESC neural differentiation 7.53
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 7.44
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 7.44
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 7.43
Hepatocyte maturation 7.39
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 7.34
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 7.19
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 7.19
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 7.15
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 7.15
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 7.06
Postnatal lipids drive hepatocyte maturation 6.95
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 6.94
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 6.89
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 6.83
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.65
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.65
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 6.63
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 6.59
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.55
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.54
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 6.42
The expression profiles of GBC liver metastasis 6.39
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 6.19
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 6.19
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 6.19
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 6.0
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 6.0
Derivation and differentiation of haploid human embryonic stem cells 5.97
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.95
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.79
Single cell transcriptome of peritoneal cells 5.76
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.67
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 5.64
RNA-seq of naive and primed ES cells 5.61
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 5.54
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 5.53
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 5.53
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 5.47
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.45
Repurposing of promoters and enhancers during mammalian evolution 5.42
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 5.42
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 5.37
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.33
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 5.25
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 5.15
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.13
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 5.11
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 5.09
mRNA sequencing of oropharyngeal cancer cell lines 5.07
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 5.04
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 5.04
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.98
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 4.97
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 4.97
The comparison of high-throughput single-cell RNA-seq methods 4.76
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 4.75
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.75
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.67
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.56
Engineering Patient-Specific Tissue Implants 4.52
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.51
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.44
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 4.42
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 4.41
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.31
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 4.31
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 4.31
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.15
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.12
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.03
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.02
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 4.0
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.97
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 3.88
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.87
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 3.83
Role of FGFR1 in neuronal devlopment 3.77
Hepatic transcriptome of pediatric hepatoblastoma. 3.61
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 3.6
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 3.6
RNA seq_PDX2_SHP099 3.52
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.4
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.4
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 3.38
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.34
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 3.34
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.22
Molecular Criteria for Defining the Naive Human Pluripotent State 3.21
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.07
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.94
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.89
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.79
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.78
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 2.7
Direct Isolation and Characterization of Human Nephron Progenitors. 2.68
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.64
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.61
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 2.6
Transcriptome of EBV-infected gastric cancer cell lines 2.49
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.49
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 2.37
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.33
CUREfast: Accelerating research with families 2.28
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 2.22
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 2.19
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 2.13
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 2.13
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 2.09
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.96
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.93
RNA-Seq in PWS iPSC-derived neurons 1.92
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.88
RNA-seq of SCLC PDX models treated with EP 1.81
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.72
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.7
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.69
Entrectinib Resistance in a Neuroblastoma Xenograft Model 1.66
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.54
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 1.47
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.46
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.44
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.41
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.34
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.34
Total RNA sequencing of APC mutant and wt colonic organoids 1.31
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.25
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.25
CHCHD2 gene KO effect in iPSC drived motor neurons 1.18
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.16
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.16
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.09
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 1.07
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 1.05
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.0
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.92
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.92
ML29755 RNA-seq data 0.91
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.91
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.89
hNSCs siRNA NOVA2 0.84
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.75
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
RNA-Seq and expression data from human adipose tissue 0.66
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.66
Identification of a LIF-responsive replication-competent human β cell 0.65
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.64
Fibroblasts in cholesteatoma activate osteoclasts. 0.58
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.56
Comparative Analysis of Cas9 Activators Across Multiple Species 0.54
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.39
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.39
Single-cell analysis of adult human ovary using 10X genomics 0.33
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.3
Ribosomal protein RPL26 is the principal target of UFMylation 0.29
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.28
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.28
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.25
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.25
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.22
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 0.19
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.19
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.19
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 0.17
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 0.16
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 0.15
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 0.15
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.15
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.13
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.11
FOXP2's impact on the primate transcriptome 0.08
The contribution of Alu exons to the human proteome 0.07
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation